Tämä sivu käännettiin automaattisesti, eikä käännösten tarkkuutta voida taata. Katso englanninkielinen versio lähdetekstiä varten.

The Relationship Between Oxytocin Massage in Mothers With Insufficient Milk Production in the Early Postpartum Period and Breastfeeding Self-Efficacy and Milk Let-down Reflex: A Randomized Controlled Study

keskiviikko 20. toukokuuta 2026 päivittänyt: Demet Cakir, Tokat Gaziosmanpasa University
This randomized controlled trial aims to evaluate the effects of oxytocin massage on breastfeeding self-efficacy and the milk ejection reflex among mothers experiencing insufficient milk supply in the early postpartum period. Insufficient milk supply is a common issue often linked to maternal stress, which can inhibit oxytocin release and negatively impact the milk ejection reflex and the mother's confidence in breastfeeding. By applying oxytocin massage to the thoracic paravertebral region, this study seeks to stimulate oxytocin release non-pharmacologically. The primary objective is to determine whether this intervention improves physiological milk flow and enhances maternal breastfeeding self-efficacy compared to routine postpartum care.

Tutkimuksen yleiskatsaus

Tila

Rekrytointi

Interventio / Hoito

Yksityiskohtainen kuvaus

Breastfeeding is a fundamental public health intervention in protecting maternal and neonatal health, and the early postpartum period is particularly critical for the initiation and maintenance of lactation (WHO, 2023). Effective breastfeeding initiated in the first hours and days of life reduces neonatal mortality and positively affects long-term mother-infant health (Victora et al., 2023). However, physiological, psychological, and environmental factors experienced in the early postpartum period can negatively impact breastfeeding success. During this period, the mother's hormonal balance, birth experience, fatigue level, and emotional adaptation are among the main factors determining the quality of the breastfeeding process.

One of the most frequently reported problems by mothers in the early postpartum period is insufficient milk supply or perceived insufficient milk (Brown et al., 2022). Perceived insufficient milk is often related to maternal stress, anxiety, pain, and negative perceptions regarding the birth experience rather than objective milk production (Fallon et al., 2021). Increased stress levels can suppress oxytocin release through the hypothalamic-pituitary axis, thereby reducing the effectiveness of the milk ejection reflex (Uvnäs-Moberg et al., 2020). Inadequate realization of the milk ejection reflex can lead to delayed milk flow despite a feeling of fullness in the breast, making the mother's breastfeeding experience difficult. Recurrent negative experiences can lower the mother's perception of self-efficacy regarding breastfeeding (Dennis & Jackson, 2021).

The lactation process is regulated by the coordinated action of prolactin and oxytocin hormones. While prolactin is responsible for milk synthesis, oxytocin ensures the realization of the milk ejection reflex (Uvnäs-Moberg et al., 2020). Oxytocin is not only a peripheral hormone but also a neuropeptide that has stress-reducing and attachment-supporting effects at the central nervous system level. Increased oxytocin levels are reported to be associated with maternal relaxation, a sense of trust, and mother-infant bonding (Feldman, 2021). Therefore, non-pharmacological interventions that support oxytocin release can positively affect both physiological milk flow and the mother's psychological adaptation process.

Oxytocin massage is an intervention applied to the thoracic paravertebral region that aims to increase oxytocin release through afferent nerve stimulation. Although this method, frequently used in clinical practice, has been reported to have positive effects on milk production and milk volume (Kusumastuti et al., 2021; Pramono et al., 2022), it is observed that randomized controlled trials evaluating the effectiveness of the milk ejection reflex and its relationship with psychosocial variables together are limited. The fact that most existing studies have a quasi-experimental design highlights the need to strengthen the level of evidence.

Breastfeeding self-efficacy is based on the concept of self-efficacy, which is grounded in Bandura's social cognitive theory and expresses an individual's belief that they can successfully perform a specific behavior (Dennis, 2020). Self-efficacy is nourished by four main sources: performance accomplishments, verbal persuasion, vicarious experience (observational learning), and physiological-emotional states. Physiological difficulties and inadequacy in the milk ejection reflex experienced in the early postpartum period can negatively affect the mother's physiological-emotional state, leading to a decrease in self-efficacy perception (Brady et al., 2021). Low breastfeeding self-efficacy has been found to be associated with early cessation of breastfeeding (Fallon et al., 2021).

When the literature is reviewed, although there are studies examining the effect of oxytocin massage on milk volume, it is noteworthy that randomized controlled trials addressing the milk ejection reflex and breastfeeding self-efficacy together are limited. The lack of studies with a high level of evidence aimed at evaluating these variables together, especially in mothers experiencing insufficient milk supply, creates an important gap in terms of developing evidence-based midwifery practices. In this context, this study aimed to investigate the effect of oxytocin massage applied to mothers with insufficient milk supply in the early postpartum period on breastfeeding self-efficacy and the milk ejection reflex using a randomized controlled design. The study is expected to contribute to the literature regarding the effectiveness of non-pharmacological interventions for breastfeeding support in the early postpartum period.

Hypotheses:

H0a: Oxytocin massage applied to mothers with insufficient milk supply in the early postpartum period does not affect breastfeeding self-efficacy.

H1a: Oxytocin massage applied to mothers with insufficient milk supply in the early postpartum period leads to a change in the level of breastfeeding self-efficacy over time.

H0b: Oxytocin massage applied to mothers with insufficient milk supply in the early postpartum period does not affect the milk ejection reflex.

H1b: Oxytocin massage applied to mothers with insufficient milk supply in the early postpartum period leads to a change in the level of the milk ejection reflex over time.

Opintotyyppi

Interventio

Ilmoittautuminen (Arvioitu)

128

Vaihe

  • Ei sovellettavissa

Yhteystiedot ja paikat

Tässä osiossa on tutkimuksen suorittajien yhteystiedot ja tiedot siitä, missä tämä tutkimus suoritetaan.

Opiskeluyhteys

Opiskelupaikat

    • Merkez
      • Kahramanmaraş, Merkez, Turkki (Türkiye), 46100
        • Rekrytointi
        • Kahramanmaras Sutcu Imam University Hospital, Department of Obstetrics and Gynecology, Delivery Room

Osallistumiskriteerit

Tutkijat etsivät ihmisiä, jotka sopivat tiettyyn kuvaukseen, jota kutsutaan kelpoisuuskriteereiksi. Joitakin esimerkkejä näistä kriteereistä ovat henkilön yleinen terveydentila tai aiemmat hoidot.

Kelpoisuusvaatimukset

Opintokelpoiset iät

  • Aikuinen
  • Vanhempi Aikuinen

Hyväksyy terveitä vapaaehtoisia

Joo

Kuvaus

Inclusion Criteria:

  • Being 18 years of age or older
  • Being in the early postpartum period (within the first 24-48 hours after birth)
  • Having had a single, live birth via vaginal delivery or cesarean section
  • Having a term (≥37 weeks) and healthy baby
  • Being in the same room as the baby (rooming-in practice)
  • Having started breastfeeding
  • Reporting insufficient milk production or expressing difficulty with the milk let-down reflex
  • Not having a cognitive, neurological, or serious psychiatric problem that would impede communication
  • Voluntary participation in the study and providing written informed consent

Exclusion Criteria:

  • Having given birth preterm (<37 weeks)
  • Having given birth as a result of a multiple pregnancy
  • Having been admitted to the neonatal intensive care unit (NICU)
  • The baby having a congenital anomaly that prevents breastfeeding (e.g., cleft lip and palate)
  • The mother having medical conditions that contraindicate breastfeeding (HIV infection, active tuberculosis, etc.)
  • The mother developing serious postpartum complications (postpartum hemorrhage, eclampsia, serious infection, etc.)
  • The presence of anatomical or pathological conditions related to the breast that may prevent breastfeeding (advanced mastitis, breast abscess, etc.)
  • The presence of skin lesions, surgical incisions, or infections in the back that would prevent the application of oxytocin massage
  • Failure to complete the intervention or wishing to withdraw from the study will be excluded.

Opintosuunnitelma

Tässä osiossa on tietoja tutkimussuunnitelmasta, mukaan lukien kuinka tutkimus on suunniteltu ja mitä tutkimuksella mitataan.

Miten tutkimus on suunniteltu?

Suunnittelun yksityiskohdat

  • Ensisijainen käyttötarkoitus: Hoito
  • Jako: Satunnaistettu
  • Inventiomalli: Rinnakkaistehtävä
  • Naamiointi: Ei mitään (avoin tarra)

Aseet ja interventiot

Osallistujaryhmä / Arm
Interventio / Hoito
Kokeellinen: Oxytocin Massage Group
Mothers assigned to this group will receive a single session of oxytocin massage prior to breastfeeding. The massage will be applied by the researcher to the thoracic paravertebral region (T4-T6 level) using rhythmic and circular movements for 20-30 minutes, in accordance with a standardized protocol.
Oxytocin massage was applied to the mothers assigned to the experimental group as a non-pharmacological intervention. According to the standardized intervention protocol, a single session of oxytocin massage, lasting for 20 to 30 minutes in total, was performed on the thoracic and scapular regions of the back. The massage was administered by the researcher using rhythmic and circular movements focusing on the paravertebral area to stimulate afferent nerve pathways and promote endogenous oxytocin release. This aimed to facilitate the milk ejection reflex and support breastfeeding self-efficacy in the early postpartum period.
Ei väliintuloa: Routine Care Group
Mothers assigned to this group will not receive any additional experimental interventions. They will only receive the institution's routine standard postpartum hospital care.

Mitä tutkimuksessa mitataan?

Ensisijaiset tulostoimenpiteet

Tulosmittaus
Toimenpiteen kuvaus
Aikaikkuna
Breastfeeding Self-Efficacy Scale-Short Form
Aikaikkuna: Baseline (immediately before the intervention) and immediately after the single 20-30 minute session of oxytocin massage.
Breastfeeding self-efficacy was assessed using the 14-item Breastfeeding Self-Efficacy Scale-Short Form (BSES-SF). It is a 5-point Likert-type scale (1 = "not at all confident" to 5 = "always confident"). The total score ranges from 14 to 70. Higher scores indicate a higher level of breastfeeding self-efficacy.
Baseline (immediately before the intervention) and immediately after the single 20-30 minute session of oxytocin massage.

Toissijaiset tulostoimenpiteet

Tulosmittaus
Toimenpiteen kuvaus
Aikaikkuna
Perception of Insufficient Milk Supply Questionnaire
Aikaikkuna: Baseline (immediately before the intervention) and immediately after the single 20-30 minute session of oxytocin massage.
Maternal perception of milk supply was evaluated using this 6-item questionnaire. The first question is a yes/no item ("Do you believe you produce enough milk to satisfy your baby?"). The remaining 5 items are scored from 0 to 10 (0 = completely insufficient, 10 = completely sufficient). The total score for these 5 items ranges from 0 to 50. Higher scores indicate a higher perception of sufficient milk supply.
Baseline (immediately before the intervention) and immediately after the single 20-30 minute session of oxytocin massage.

Yhteistyökumppanit ja tutkijat

Täältä löydät tähän tutkimukseen osallistuvat ihmiset ja organisaatiot.

Tutkijat

  • Päätutkija: Elif TAĞTEKİN, student, Kahramanmaras Sutcu Imam University Department of Midwifery

Opintojen ennätyspäivät

Nämä päivämäärät seuraavat ClinicalTrials.gov-sivustolle lähetettyjen tutkimustietueiden ja yhteenvetojen edistymistä. National Library of Medicine (NLM) tarkistaa tutkimustiedot ja raportoidut tulokset varmistaakseen, että ne täyttävät tietyt laadunvalvontastandardit, ennen kuin ne julkaistaan ​​julkisella verkkosivustolla.

Opi tärkeimmät päivämäärät

Opiskelun aloitus (Todellinen)

Tiistai 12. toukokuuta 2026

Ensisijainen valmistuminen (Todellinen)

Tiistai 12. toukokuuta 2026

Opintojen valmistuminen (Arvioitu)

Lauantai 12. syyskuuta 2026

Opintoihin ilmoittautumispäivät

Ensimmäinen lähetetty

Keskiviikko 20. toukokuuta 2026

Ensimmäinen toimitettu, joka täytti QC-kriteerit

Keskiviikko 20. toukokuuta 2026

Ensimmäinen Lähetetty (Todellinen)

Keskiviikko 27. toukokuuta 2026

Tutkimustietojen päivitykset

Viimeisin päivitys julkaistu (Todellinen)

Keskiviikko 27. toukokuuta 2026

Viimeisin lähetetty päivitys, joka täytti QC-kriteerit

Keskiviikko 20. toukokuuta 2026

Viimeksi vahvistettu

Sunnuntai 1. helmikuuta 2026

Lisää tietoa

Tähän tutkimukseen liittyvät termit

Yksittäisten osallistujien tietojen suunnitelma (IPD)

Aiotko jakaa yksittäisten osallistujien tietoja (IPD)?

EI

IPD-suunnitelman kuvaus

Individual participant data will not be shared to protect the privacy and confidentiality of the postpartum mothers involved in the study. The informed consent obtained from the participants strictly limits the use of their data to this specific research only. Furthermore, the institutional ethics committee approval does not cover public data sharing or secondary analysis by third parties.

Lääke- ja laitetiedot, tutkimusasiakirjat

Tutkii yhdysvaltalaista FDA sääntelemää lääkevalmistetta

Ei

Tutkii yhdysvaltalaista FDA sääntelemää laitetuotetta

Ei

Nämä tiedot haettiin suoraan verkkosivustolta clinicaltrials.gov ilman muutoksia. Jos sinulla on pyyntöjä muuttaa, poistaa tai päivittää tutkimustietojasi, ota yhteyttä register@clinicaltrials.gov. Heti kun muutos on otettu käyttöön osoitteessa clinicaltrials.gov, se päivitetään automaattisesti myös verkkosivustollemme .

Tilaa